Related Experiment Video
Updated: Aug 13, 2026
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Management of lipid disorders
1Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, USA.
Rheumatic Diseases Clinics of North America
|September 1, 1999
Summary
Patients with rheumatologic disorders have a high risk of atherosclerotic cardiovascular disease (ASCVD). Aggressively treating lipid disorders by reducing LDL cholesterol is crucial for lowering ASCVD risk in these individuals.
Area of Science:
- Rheumatology
- Cardiology
- Lipidology
Background:
- Atherosclerotic cardiovascular disease (ASCVD) is prevalent in patients with rheumatologic disorders.
- Lipid disorders are a significant risk factor for ASCVD and its clinical sequelae.
Purpose of the Study:
- To emphasize the importance of screening and managing lipid disorders in patients with rheumatologic conditions.
- To highlight the benefits of LDL cholesterol reduction in mitigating cardiovascular risk.
Main Methods:
- The abstract suggests obtaining plasma lipid profiles in all patients diagnosed with rheumatologic disorders.
- It advocates for aggressive treatment of identified lipid disorders.
Main Results:
- Reduction of LDL cholesterol and effective management of lipid disorders are proven strategies to decrease ASCVD risk.
- Aggressive lipid management aims to reduce the incidence of ASCVD events.
Conclusions:
- Plasma lipid levels should be routinely assessed in individuals with rheumatologic disorders.
- Proactive treatment of lipid disorders is essential for cardiovascular risk reduction in this patient population.
- Clinical management requires attention to potential side effects and drug-drug interactions specific to rheumatologic patients.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:18Lipids: Dietary Sources and Requirements
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
01:24Overview of Lipid Metabolism
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:26Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...